RÉSUMÉ
The present study was assumed that Nacetylcysteine (AC) might improve cognitive function in adolescent rats with hypothyroidism through various mechanisms. Sixty adolescent rats were randomly divided into the following groups: Vehicle (received normal saline intraperitoneally (IP)); Propylthiouracil (PTU)induced hypothyroidism (0.05%, dissolved in drinking water); Hypothyroid rats were IP treated with different doses of AC (50, 100, and 150 mg/kg/day) for a period of six weeks; Normal rats treated with the highest doses of AC (150 mg/kg/day). Behavioral and biochemical analyses were studied for all groups. In the Morris water maze test, AC significantly reduced both the time to find the hidden platform and the distance travelled as compared to nontreated hypothyroid rats. In the passive avoidance test, the latency of entering the dark chamber was significantly increased by AC, whereas decreased the time spent in the darkroom of the chamber compared to the hypothyroid rats. In biochemical results, AC reduced both malondialdehyde content and nitrite while increased the thiol content, catalase and superoxide dismutase enzymes activity in both the cortex and the hippocampus, and a notable improvement in brainderived neurotrophic factor (BDNF) levels in hippocampal tissues of the hypothyroid rats, while decreasing the level of interleukin6 in rat hippocampal region. Therefore, based on the results, the beneficial effects of AC on cognitive impairment in adolescent hypothyroid rats are probably related to its antioxidant properties and notable improvement in BDNF levels.
Sujet(s)
Acétylcystéine , Facteur neurotrophique dérivé du cerveau , Hippocampe , Hypothyroïdie , Stress oxydatif , Animaux , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Mâle , Hypothyroïdie/métabolisme , Hypothyroïdie/induit chimiquement , Hypothyroïdie/complications , Acétylcystéine/pharmacologie , Facteur neurotrophique dérivé du cerveau/métabolisme , Rats , Stress oxydatif/effets des médicaments et des substances chimiques , Rat Wistar , Troubles de la mémoire/traitement médicamenteux , Troubles de la mémoire/prévention et contrôle , Troubles de la mémoire/étiologie , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Inflammation/métabolisme , Inflammation/traitement médicamenteux , Antioxydants/pharmacologieRÉSUMÉ
The role of serotonin in human behaviour is informed by approaches which allow in vivo modification of synaptic serotonin. However, characterising the effects of increased serotonin signalling in human models of behaviour is challenging given the limitations of available experimental probes, notably selective serotonin reuptake inhibitors. Here we use a now-accessible approach to directly increase synaptic serotonin in humans (a selective serotonin releasing agent) and examine its influence on domains of behaviour historically considered core functions of serotonin. Computational techniques, including reinforcement learning and drift diffusion modelling, explain participant behaviour at baseline and after week-long intervention. Reinforcement learning models reveal that increasing synaptic serotonin reduces sensitivity for outcomes in aversive contexts. Furthermore, increasing synaptic serotonin enhances behavioural inhibition, and shifts bias towards impulse control during exposure to aversive emotional probes. These effects are seen in the context of overall improvements in memory for neutral verbal information. Our findings highlight the direct effects of increasing synaptic serotonin on human behaviour, underlining its role in guiding decision-making within aversive and more neutral contexts, and offering implications for longstanding theories of central serotonin function.
Sujet(s)
Sérotonine , Humains , Sérotonine/métabolisme , Mâle , Femelle , Adulte , Jeune adulte , , Apprentissage par évitement/effets des médicaments et des substances chimiques , Apprentissage par évitement/physiologie , Émotions/physiologie , Inhibition psychologique , Inbiteurs sélectifs de la recapture de la sérotonine/pharmacologie , Apprentissage/physiologie , Prise de décision/physiologie , Mémoire/physiologie , Mémoire/effets des médicaments et des substances chimiquesRÉSUMÉ
Brain rhythms provide the timing for recruitment of brain activity required for linking together neuronal ensembles engaged in specific tasks. The γ-oscillations (30 to 120 Hz) orchestrate neuronal circuits underlying cognitive processes and working memory. These oscillations are reduced in numerous neurological and psychiatric disorders, including early cognitive decline in Alzheimer's disease (AD). Here, we report on a potent brain-permeable small molecule, DDL-920 that increases γ-oscillations and improves cognition/memory in a mouse model of AD, thus showing promise as a class of therapeutics for AD. We employed anatomical, in vitro and in vivo electrophysiological, and behavioral methods to examine the effects of our lead therapeutic candidate small molecule. As a novel in central nervous system pharmacotherapy, our lead molecule acts as a potent, efficacious, and selective negative allosteric modulator of the γ-aminobutyric acid type A receptors most likely assembled from α1ß2δ subunits. These receptors, identified through anatomical and pharmacological means, underlie the tonic inhibition of parvalbumin (PV) expressing interneurons (PV+INs) critically involved in the generation of γ-oscillations. When orally administered twice daily for 2 wk, DDL-920 restored the cognitive/memory impairments of 3- to 4-mo-old AD model mice as measured by their performance in the Barnes maze. Our approach is unique as it is meant to enhance cognitive performance and working memory in a state-dependent manner by engaging and amplifying the brain's endogenous γ-oscillations through enhancing the function of PV+INs.
Sujet(s)
Maladie d'Alzheimer , Cognition , Modèles animaux de maladie humaine , Rythme gamma , Animaux , Maladie d'Alzheimer/traitement médicamenteux , Souris , Cognition/effets des médicaments et des substances chimiques , Rythme gamma/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Récepteurs GABA-A/métabolisme , Souris transgéniques , Humains , Mâle , Mémoire à court terme/effets des médicaments et des substances chimiques , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Alanine/analogues et dérivés , AzépinesRÉSUMÉ
This research article elucidates the pivotal role of radiopharmacy in the contemporary landscape, underscoring its potential therapeutic efficacy in addressing symptoms associated with aged-related neurocognitive processes. Clinical trials, characterized by the judicious application of modest radiation doses, exemplified by low-dose radon, have yielded affirmative outcomes in the amelioration of aged, related symptoms. MATERIAL AND METHODS: The study was conducted on an animal model. The effect of low doses of radon on cognitive processes is being studied by inhalation of randomized mineral water. Changes in the clinical picture were studied using behavioral tests, namely the Barnes maze tests. At the cellular level, radon-contained water inhalation causes different changes: in the fraction of synaptic membranes (determined by Na, K-ATPase activity), aged, related changes by telomerase activity and oxidative stress level changes. RESULTS: Our studies show that age-related changes in brain tissue are less noticeable after radon inhalation, namely, the concentration of amyloid plaques decreases in a group of aged rats after radon therapy. A significant improvement in cognitive function was observed after radon inhalation in aged rats. CONCLUSION: The results show that exposure to radon-containing mineral water leads to improved spatial perception, potentially improving age-related cognitive functions not only at the level of neurocognitive tests, but also changes at the level of cellular functioning.
Sujet(s)
Eau minérale , Radon , Animaux , Eau minérale/usage thérapeutique , Radon/usage thérapeutique , Rats , Mâle , Comportement animal/effets des radiations , Comportement animal/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Administration par inhalation , Stress oxydatif/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Mémoire/effets des radiations , Vieillissement/physiologie , Encéphale/effets des radiations , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Cognition/effets des radiations , Cognition/effets des médicaments et des substances chimiques , Rat Wistar , Sodium-Potassium-Exchanging ATPase/métabolismeRÉSUMÉ
Synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD), is an essential phenomenon in memory formation as well as maintenance along with many other cognitive functions, such as those needed for coping with external stimuli. Synaptic plasticity consists of gradual changes in the biochemistry and morphology of pre- and postsynaptic neurons, particularly in the hippocampus. Consuming marijuana as a primary source of exocannabinoids immediately impairs attention and working memory-related tasks. Evidence regarding the effects of cannabinoids on LTP and memory is contradictory. While cannabinoids can affect a variety of specific cannabinoid receptors (CBRs) and nonspecific receptors throughout the body and brain, they exert miscellaneous systemic and local cerebral effects. Given the increasing use of cannabis, mainly among the young population, plus its potential adverse long-term effects on learning and memory processes, it could be a future global health challenge. Indeed, the impact of cannabinoids on memory is multifactorial and depends on the dosage, timing, formula, and route of consumption, plus the background complex interaction of the endocannabinoids system with other cerebral networks. Herein, we review how exogenously administrated organic cannabinoids, CBRs agonists or antagonists, and endocannabinoids can affect LTP and synaptic plasticity through various receptors in interaction with other cerebral pathways and primary neurotransmitters.
Sujet(s)
Cannabinoïdes , Potentialisation à long terme , Mémoire , Plasticité neuronale , Cannabinoïdes/pharmacologie , Cannabinoïdes/métabolisme , Humains , Plasticité neuronale/effets des médicaments et des substances chimiques , Animaux , Potentialisation à long terme/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Endocannabinoïdes/métabolisme , Endocannabinoïdes/pharmacologie , Récepteurs de cannabinoïdes/métabolisme , Dépression synaptique à long terme/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiquesRÉSUMÉ
The potential long-term effects of anesthesia on cognitive development, especially in neonates and infants, have raised concerns. However, our understanding of its underlying mechanisms and effective treatments is still limited. In this study, we found that early exposure to isoflurane (ISO) impaired fear memory retrieval, which was reversed by dexmedetomidine (DEX) pre-treatment. Measurement of c-fos expression revealed that ISO exposure significantly increased neuronal activation in the zona incerta (ZI). Fiber photometry recording showed that ZI neurons from ISO mice displayed enhanced calcium activity during retrieval of fear memory compared to the control group, while DEX treatment reduced this enhanced calcium activity. Chemogenetic inhibition of ZI neurons effectively rescued the impairments caused by ISO exposure. These findings suggest that the ZI may play a pivotal role in mediating the cognitive effects of anesthetics, offering a potential therapeutic target for preventing anesthesia-related cognitive impairments.
Sujet(s)
Peur , Isoflurane , Troubles de la mémoire , Zona incerta , Isoflurane/pharmacologie , Isoflurane/effets indésirables , Animaux , Peur/effets des médicaments et des substances chimiques , Souris , Troubles de la mémoire/induit chimiquement , Zona incerta/effets des médicaments et des substances chimiques , Mâle , Anesthésiques par inhalation/effets indésirables , Anesthésiques par inhalation/pharmacologie , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Souris de lignée C57BL , Dexmédétomidine/pharmacologie , Femelle , Protéines proto-oncogènes c-fos/métabolisme , Mémoire/effets des médicaments et des substances chimiquesRÉSUMÉ
BACKGROUND: Autism spectrum disorder (ASD) is the fastest-growing child neuropsychiatric condition. Cognitive dysfunctions such as memory impairments are experienced by patients along with social disturbances and repetitive/stereotypic movements. We have used the radial arm maze (RAM), for measurement of working and reference memory errors in an animal model of autism. In addition, the potential effects of agmatine, an endogenous NMDA antagonist, on RAM performance and autistic-like behaviors were assessed. METHODS: Autism was modeled by valproic acid (VPA) administration at gestational Day 12.5. Autism-associated behaviors in male offspring were examined in an open field test (OFT) and three-chambered test (TCT) on postnatal days 50-51. Thereafter, the animals were trained in the RAM (PND 55) until they attained the criteria of 80% correct choices during five consecutive trials. Forty-eight hours after the acquisition of criteria, agmatine was injected 30 min before subsequent behavioral testing, which included the retention phase of the RAM, OFT, and TCT. RESULTS: VPA-treated and intact rats showed the same performance in RAM, and acute injection of agmatine rescued social and anxiety-like behavior induced by VPA without the effect on RAM. CONCLUSION: In a rat model of autism, spatial learning, and memory did not change. Agmatine rescued social and anxiety-like behavior in autistic animals.
Sujet(s)
Agmatine , Trouble autistique , Comportement animal , Modèles animaux de maladie humaine , Apprentissage du labyrinthe , Animaux , Agmatine/pharmacologie , Mâle , Rats , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Trouble autistique/traitement médicamenteux , Trouble autistique/psychologie , Comportement animal/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Acide valproïque/pharmacologie , Femelle , GrossesseRÉSUMÉ
Social recognition is essential for the formation of social structures. Many times, recognition comes with lesser exploration of familiar animals. This lesser exploration has led to the assumption that recognition may be a habituation memory. The underlying memory mechanisms and the thereby acquired cortical representations of familiar mice have remained largely unknown, however. Here, we introduce an approach directly examining the recognition process from volatile body odors among male mice. We show that volatile body odors emitted by mice are sufficient to identify individuals and that more salience is assigned to familiar mice. Familiarity is encoded by reinforced population responses in two olfactory cortex hubs and communicated to other brain regions. The underlying oxytocin-induced plasticity promotes the separation of the cortical representations of familiar from other mice. In summary, neuronal encoding of familiar animals is distinct and utilizes the cortical representational space more broadly, promoting storage of complex social relationships.
Sujet(s)
Cognition , Odorisants , Ocytocine , , Animaux , Ocytocine/pharmacologie , Ocytocine/métabolisme , Mâle , Souris , /physiologie , /effets des médicaments et des substances chimiques , Cognition/effets des médicaments et des substances chimiques , Cognition/physiologie , Souris de lignée C57BL , Cortex olfactif/physiologie , Comportement social , Plasticité neuronale/effets des médicaments et des substances chimiques , Odorat/physiologie , Odorat/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Mémoire/physiologie , Comportement animal/effets des médicaments et des substances chimiquesRÉSUMÉ
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and memory loss. Imipramine, a tricyclic antidepressant, has potent anti-inflammatory and antioxidant properties in the central nervous system. The aim of this study was to investigate the neuroprotective effects of imipramine on streptozotocin (STZ)-induced memory impairment. Male Wistar rats received an intracerebroventricular injection of STZ (3 mg/kg, 3 µl/ventricle) using the stereotaxic apparatus. The Morris water maze and passive avoidance tests were used to evaluate cognitive functions. 24 h after the STZ injection, imipramine was administered intraperitoneally at doses of 10 or 20 mg/kg for 14 consecutive days. The mRNA and protein levels of neurotrophic factors (BDNF and GDNF) and pro-inflammatory cytokines (IL-6, IL-1ß, and TNF-α) were measured in the hippocampus using real-time PCR and ELISA techniques, respectively. In addition, real-time PCR was used to evaluate the mRNA levels of markers associated with neurogenesis (Nestin, DCX, and Ki67) and mitochondrial biogenesis (PGC-1α, NRF-1, and TFAM). The results showed that imipramine, especially at a dose of 20 mg/kg, effectively improved STZ-induced memory impairment. This improvement was associated with an increase in neurogenesis and neurotrophic factors and a decrease in neuroinflammation and mitochondrial biogenesis dysfunction. Based on these results, imipramine appears to be a promising therapeutic option for improving cognitive functions in neurodegenerative diseases such as AD.
Sujet(s)
Maladie d'Alzheimer , Modèles animaux de maladie humaine , Hippocampe , Imipramine , Neurogenèse , Biogenèse des organelles , Rat Wistar , Streptozocine , Animaux , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/métabolisme , Mâle , Neurogenèse/effets des médicaments et des substances chimiques , Imipramine/pharmacologie , Rats , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Protéine doublecortine , Maladies neuro-inflammatoires/traitement médicamenteux , Mémoire/effets des médicaments et des substances chimiques , Facteur neurotrophique dérivé du cerveau/métabolisme , Troubles de la mémoire/traitement médicamenteux , Neuroprotecteurs/pharmacologie , Antidépresseurs tricycliques/pharmacologie , Facteur neurotrophique dérivé des cellules gliales/métabolisme , Facteur neurotrophique dérivé des cellules gliales/génétique , Cytokines/métabolismeRÉSUMÉ
Labilization-reconsolidation, which relies on retrieval, has been considered an opportunity to attenuate the negative aspects of traumatic memories. A therapeutic strategy based on reconsolidation blockade is deemed more effective than current therapies relying on memory extinction. Nevertheless, extremely stressful memories frequently prove resistant to this process. Here, after inducing robust fear memory in mice through strong fear conditioning, we examined the possibility of rendering it susceptible to pharmacological modulation based on the degree of generalized fear (GF). To achieve this, we established an ordered gradient of GF, determined by the perceptual similarity between the associated context (CA) and non-associated contexts (CB, CC, CD, and CE) to the aversive event. We observed that as the exposure context became less similar to CA, the defensive pattern shifted from passive to active behaviors in both male and female mice. Subsequently, in conditioned animals, we administered propranolol after exposure to the different contexts (CA, CB, CC, CD or CE). In males, propranolol treatment resulted in reduced freezing time and enhanced risk assessment behaviors when administered following exposure to CA or CB, but not after CC, CD, or CE, compared to the control group. In females, a similar change in behavioral pattern was observed with propranolol administered after exposure to CC, but not after the other contexts. These results highlight the possibility of indirectly manipulating a robust contextual fear memory by controlling the level of generalization during recall. Additionally, it was demonstrated that the effect of propranolol on reconsolidation would not lead to a reduction in fear memory per se, but rather to its reorganization resulting in greater behavioral flexibility (from passive to active behaviors). Finally, from a clinical viewpoint, this would be of considerable relevance since following this strategy could make the treatment of psychiatric disorders associated with traumatic memory formation more effective and less stressful.
Sujet(s)
Conditionnement classique , Peur , Propranolol , Peur/effets des médicaments et des substances chimiques , Peur/physiologie , Animaux , Mâle , Propranolol/pharmacologie , Femelle , Souris , Conditionnement classique/effets des médicaments et des substances chimiques , Consolidation de la mémoire/effets des médicaments et des substances chimiques , Consolidation de la mémoire/physiologie , Souris de lignée C57BL , Mémoire/effets des médicaments et des substances chimiques , Mémoire/physiologie , /effets des médicaments et des substances chimiques , /physiologie , Extinction (psychologie)/effets des médicaments et des substances chimiquesRÉSUMÉ
Adolescence is characterized by a critical period of maturation and growth, during which regions of the brain are vulnerable to long-lasting cognitive disturbances. Adolescent exposure to nicotine can lead to deleterious neurological and psychological outcomes. Moreover, the nicotinic acetylcholine receptor (nAChR) has been shown to play a functionally distinct role in the development of the adolescent brain. CHRNA2 encodes for the α2 subunit of nicotinic acetylcholine receptors associated with CA1 oriens lacunosum moleculare GABAergic interneurons and is associated with learning and memory. Previously, we found that adolescent male hypersensitive CHRNA2L9'S/L9' mice had impairments in learning and memory during a pre-exposure-dependent contextual fear conditioning task that could be rescued by low-dose nicotine exposure. In this study, we assessed learning and memory in female adolescent hypersensitive CHRNA2L9'S/L9' mice exposed to saline or a subthreshold dose of nicotine using a hippocampus-dependent task of pre-exposure-dependent contextual fear conditioning. We found that nicotine-treated wild-type female mice had significantly greater improvements in learning and memory than both saline-treated wild-type mice and nicotine-treated CHRNA2L9'S/L9' female mice. Thus, hyperexcitability of CHRNA2 in female adolescent mice ablated the nicotine-mediated potentiation of learning and memory seen in wild-types. Our results indicate that nicotine exposure during adolescence mediates sexually dimorphic patterns of learning and memory, with wild-type female adolescents being more susceptible to the effects of sub-threshold nicotine exposure. To understand the mechanism underlying sexually dimorphic behavior between hyperexcitable CHRNA2 mice, it is critical that further research be conducted.
Sujet(s)
Peur , Hippocampe , Mémoire , Nicotine , Récepteurs nicotiniques , Animaux , Récepteurs nicotiniques/métabolisme , Nicotine/pharmacologie , Femelle , Souris , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Peur/effets des médicaments et des substances chimiques , Peur/physiologie , Mémoire/effets des médicaments et des substances chimiques , Mémoire/physiologie , Agonistes nicotiniques/pharmacologie , Apprentissage/effets des médicaments et des substances chimiques , Apprentissage/physiologie , Conditionnement classique/effets des médicaments et des substances chimiques , Conditionnement classique/physiologie , Souris de lignée C57BLRÉSUMÉ
Hypochlorous acid (HOCl) is an endogenous oxidant and chlorinating agent in mammals that is effective against a broad range of microorganisms. However, the effects of exogenous HOCl on biological processes have not been reported. In this study, the effects of highly purified slightly acidic hypochlorous acid water (HP-HAW) were investigated. After the safety of oral administration of HP-HAW was confirmed, the effects of HP-HAW on glucose homeostasis were assessed in mice. HP-HAW treatment significantly improved blood glucose levels in hyperglycemic condition. Based on the 16S rRNA sequencing, HP-HAW treatment significantly increased the diversity and changed the composition of gut microbiota by decreasing the abundance of genus Romboutsia in mice fed normal chow. In obese mice, HP-HAW administration tended to improve glucose tolerance. HP-HAW also attenuated memory impairments and changes N-methyl-d-aspartate (NMDA) receptor mRNA expression in obese mice. HP-HAW treatment suppressed Il-6 mRNA expression in the hippocampus in type 2 diabetic mice. Overall, these results support HP-HAW as a potential therapeutic agent to improve or prevent glucose tolerance and memory decline via gut microbiota alteration.
Sujet(s)
Diabète de type 2 , Microbiome gastro-intestinal , Glucose , Acide hypochloreux , Animaux , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Diabète de type 2/métabolisme , Diabète de type 2/traitement médicamenteux , Diabète de type 2/microbiologie , Souris , Mâle , Glucose/métabolisme , Glycémie/métabolisme , Mémoire/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Eau/composition chimique , Souris de lignée C57BL , Diabète expérimental/métabolisme , ARN ribosomique 16S/génétiqueRÉSUMÉ
Clinical and preclinical evidence has demonstrated an increased risk for neuropsychiatric disorders following prenatal cannabinoid exposure. However, given the phytochemical complexity of cannabis, there is a need to understand how specific components of cannabis may contribute to these neurodevelopmental risks later in life. To investigate this, a rat model of prenatal cannabinoid exposure was utilized to examine the impacts of specific cannabis constituents (Δ9-tetrahydrocannabinol [THC]; cannabidiol [CBD]) alone and in combination on future neuropsychiatric liability in male and female offspring. Prenatal THC and CBD exposure were associated with low birth weight. At adolescence, offspring displayed sex-specific behavioural changes in anxiety, temporal order and social cognition, and sensorimotor gating. These phenotypes were associated with sex and treatment-specific neuronal and gene transcriptional alterations in the prefrontal cortex, and ventral hippocampus, regions where the endocannabinoid system is implicated in affective and cognitive development. Electrophysiology and RT-qPCR analysis in these regions implicated dysregulation of the endocannabinoid system and balance of excitatory and inhibitory signalling in the developmental consequences of prenatal cannabinoids. These findings reveal critical insights into how specific cannabinoids can differentially impact the developing fetal brains of males and females to enhance subsequent neuropsychiatric risk.
Sujet(s)
Comportement animal , Cannabidiol , Dronabinol , Hippocampe , Cortex préfrontal , Effets différés de l'exposition prénatale à des facteurs de risque , Modèles animaux , Animaux , Rats , Dronabinol/toxicité , Cannabidiol/toxicité , Facteurs sexuels , Cortex préfrontal/effets des médicaments et des substances chimiques , Hippocampe/effets des médicaments et des substances chimiques , Mâle , Femelle , Grossesse , Comportement animal/effets des médicaments et des substances chimiques , Rat Wistar , Mémoire/effets des médicaments et des substances chimiques , Anxiété/induit chimiquement , Cognition/effets des médicaments et des substances chimiques , Comportement impulsif/effets des médicaments et des substances chimiques , Psychoanaleptiques/toxicitéRÉSUMÉ
Global cerebral ischemia (GCI) results in damage to the neurons and leads to cognitive impairments. Berberine (BBR) is known for its neuroprotective qualities. This study aimed to investigate the effects of BBR on memory, Blood-brain barrier (BBB) permeability, biochemical factors, and neuronal structure. Sixty-three adult male Wistar rats were divided randomly into Sham (21), GCI (21), and GCI + BBR (21) groups. The GCI + BBR group received 50 mg/kg of BBR for 7 days before and 6 h after 20 min of GCI induction. After 24 h, assessments included hippocampal neuronal structure, catalase (CAT), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GPX) levels, memory performance, and BBB permeability. The GCI + BBR group reduced volume loss in the CA1 and its sublayers (oriens, pyramidal, and radiatum) compared to the GCI group (p < 0.0001, p < 0.001, p < 0.01 and p < 0.001, respectively). Additionally, the GCI + BBR group showed higher pyramidal neuron density (p < 0.0001) and number (p < 0.0001) compared to the GCI group. BBR also decreased MDA levels (p < 0.0001) and increased CAT activity (p < 0.0001) in the GCI + BBR group compared to the GCI group, with GPX and SOD activity approaching Sham levels (p < 0.0001, both). BBR demonstrated significant improvements in short and long-term memory compared to the GCI group (p < 0.01, p < 0.0001, respectively). Furthermore, BBB permeability in the GCI + BBR group was significantly reduced compared to the GCI group (p < 0.0001). These findings demonstrated BBR's potential to protect the neurons in the CA1 and BBB structures, enhance antioxidant activity, and alleviate GCI-induced memory impairments.
Sujet(s)
Berbérine , Barrière hémato-encéphalique , Hippocampe , Mémoire , Neuroprotecteurs , Rat Wistar , Animaux , Barrière hémato-encéphalique/effets des médicaments et des substances chimiques , Berbérine/pharmacologie , Mâle , Rats , Hippocampe/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Neuroprotecteurs/pharmacologie , Modèles animaux de maladie humaine , Superoxide dismutase/métabolisme , Malonaldéhyde/métabolisme , Catalase/métabolisme , Glutathione peroxidase/métabolisme , Accident ischémique transitoire/traitement médicamenteux , Encéphalopathie ischémique/traitement médicamenteuxRÉSUMÉ
Recent years, the rapid advancement of technology has raised concerns. We studied the effects of prenatal exposure to 900 MHz radiofrequency (RF) from mobile phones and the protective effects of linalool on learning and memory, and anxiety in adolescent male and female offspring rats. Pregnant rats were divided into four groups: control, wave, wave + linalool, and linalool. Rats received linalool (25mg/kg) by gavage for 21 days. Irradiation was conducted from day 0 to day 21 of pregnancy. Offsprings underwent behavioral and electrophysiological tests on days 50 and 60 after birth. Exposure to RF during pregnancy caused anxiety-like behavior in the EPM test and impairment of learning and memory in the Morris water maze and shuttle box tests. Electrophysiological properties and synaptic plasticity of the dorsal hippocampal CA3-CA1 synapse showed a decrease in fEPSP amplitude and slope. The trace element levels in both male and female offspring were consistent across all groups compared to their respective controls. In the hippocampus tissue, the levels of Fe, Cu, and Mn, as well as the Cu/Zn ratio, were significantly higher in the exposed groups (wave groups) compared to their controls. Moreover, Zn levels were significantly lower in the hippocampus tissue of the exposed groups. Linalool administration mitigated the excessive increase in Fe, Cu, Mn, and Cu/Zn ratio and normalized the disrupted levels of trace elements, except for Zn levels in both male and female offspring. Sex differences were observed in the EPM and shuttle box tests, females were more sensitive than males. In summary, our study demonstrates that prenatal exposure to mobile phone radiation induces stress-like behaviors, disrupts learning and memory, alters hippocampal electrophysiological properties and trace element balance in offspring. Treatment with linalool mitigates these deleterious effects, highlighting its potential as a therapeutic intervention. These findings contribute to our understanding of the impact of prenatal environmental exposures on neurodevelopment and offer insights into potential strategies for neuroprotection.
Sujet(s)
Monoterpènes acycliques , Hippocampe , Effets différés de l'exposition prénatale à des facteurs de risque , Animaux , Femelle , Grossesse , Monoterpènes acycliques/pharmacologie , Mâle , Rats , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/effets des radiations , Hippocampe/métabolisme , Comportement animal/effets des médicaments et des substances chimiques , Comportement animal/effets des radiations , Ondes hertziennes/effets indésirables , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/effets des radiations , Mémoire/effets des médicaments et des substances chimiques , Mémoire/effets des radiations , Anxiété/prévention et contrôle , Rat Wistar , Plasticité neuronale/effets des médicaments et des substances chimiques , Plasticité neuronale/effets des radiationsRÉSUMÉ
We examined associations between prenatal tobacco exposure (with and without cannabis exposure) and children's performance on laboratory measures of sustained attention, attentional set shifting, and working memory in middle childhood (9-12 years of child age). Participants were recruited in the first trimester of pregnancy and oversampled for prenatal tobacco exposure; with a smaller sample (n = 133; n = 34 non-substance exposed, n = 37 exposed to tobacco only, n = 62 co-exposed) invited (oversampled for co-exposure) to participate in the middle-childhood assessment (M age = 10.6, SD = 0.77; 68% Black, 20% Hispanic). Results for sustained attention indicated lower attention (percent hits) at the first epoch for tobacco only exposed compared to non-exposed and co-exposed; a trend (p = .07) towards increases in impulsive responding across time (a total of 8 epochs) for tobacco exposed (with and without cannabis) compared to non-exposed children; and a significant association between higher number of cigarettes in the first trimester and greater increases in impulsive responding across epochs. However, children prenatally exposed to tobacco (with and without cannabis) demonstrated greater short-term memory compared to children not prenatally exposed, and this difference was driven by higher scores for children prenatally co-exposed to tobacco and cannabis compared to those who were non-exposed. Overall, results suggest that prenatal tobacco exposure, especially in the first trimester, may increase risk for impulsive responding on tasks requiring sustained attention, and that co-use of cannabis did not exacerbate these associations. The higher short-term memory scores among children who were co-exposed compared to non-exposed are perplexing and need replication, particularly in studies with larger sample sizes and samples exposed only to cannabis to examine this more closely.
Sujet(s)
Attention , Mémoire à court terme , Effets différés de l'exposition prénatale à des facteurs de risque , Humains , Femelle , Effets différés de l'exposition prénatale à des facteurs de risque/psychologie , Grossesse , Attention/effets des médicaments et des substances chimiques , Enfant , Mâle , Mémoire à court terme/effets des médicaments et des substances chimiques , Cannabis/effets indésirables , Mémoire/effets des médicaments et des substances chimiques , Nicotiana/effets indésirables , Comportement impulsif/effets des médicaments et des substances chimiquesRÉSUMÉ
Fluoride (F-) exposure in organisms remains a significant concern due to its widespread presence and potential health implications. Investigating its detection and subsequent effects on behaviour in aquatic organisms like Lymnaea stagnalis provides valuable insights. Our study focused on elucidating the sensory pathways involved in F- detection and its impact on feeding and memory formation. We explored two potential detection mechanisms: direct flow across the integument onto neurons; and sensory input to the central nervous system (CNS) via the osphradium-osphradial ganglion-osphradial nerve pathway (snails use this system for olfactory sensation of multiple compounds). Injection of F- into snails did not alter feeding behaviour or central neuronal activity, suggesting that internalization might not be the primary detection mode. In contrast, severing the osphradial nerve abolished F-'s suppressive effects on feeding and memory formation, implicating the osphradial pathway in F- sensing and behavioural changes. This finding supports the idea that osphradial nerve signaling mediates the behavioural effects of F-. Our study underscores the importance of sensory pathways in F- detection and behavioural modulation in L. stagnalis. Understanding these mechanisms could provide critical insights into how organisms respond to and adapt to environmental chemical stressors like F-.
Sujet(s)
Comportement alimentaire , Fluorures , Lymnea , Mémoire , Animaux , Lymnea/physiologie , Lymnea/effets des médicaments et des substances chimiques , Comportement alimentaire/effets des médicaments et des substances chimiques , Comportement alimentaire/physiologie , Mémoire/effets des médicaments et des substances chimiques , Mémoire/physiologie , Fluorures/pharmacologie , Odorat/physiologie , Odorat/effets des médicaments et des substances chimiques , PhénotypeRÉSUMÉ
Cocoa is widely known for its health benefits, but its neurocognitive impact remains underexplored. This preclinical study aimed to investigate the effects of cocoa and cocoa polyphenols on hippocampal neuroplasticity, cognitive function and emotional behavior. Seventy young-adult C57BL/6JRj male and female mice were fed either a standard diet (CTR) or a diet enriched with 10% high-phenolic content cocoa (HPC) or low-phenolic content cocoa (LPC) for at least four weeks. In a first experiment, behavioral tests assessing exploratory behavior, emotional responses and hippocampal-dependent memory were conducted four weeks into the diet, followed by animal sacrifice a week later. Adult hippocampal neurogenesis and brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex were evaluated using immunohistochemistry and western blot. In a different experiment, hippocampal synaptic response, long-term potentiation and presynaptic-dependent short-term plasticity were studied by electrophysiology. Cocoa-enriched diets had minimal effects on exploratory activity and anxiety-like behavior, except for reduced locomotion in the LPC group. Only the HPC diet enhanced object recognition memory, while place recognition memory and spatial navigation remained unaffected. The HPC diet also increased adult hippocampal neurogenesis, boosting the proliferation, survival and number of young adult-born neurons. However, both cocoa-enriched diets increased immobility in the forced swimming test and hippocampal BDNF expression. Hippocampal electrophysiology revealed no alterations in neuroplasticity among diets. The results were mostly unaffected by sex. Overall, the HPC diet demonstrated greater potential regarding cognitive and neuroplastic benefits, suggesting a key role of cocoa flavanols in dietary interventions aimed at enhancing brain health.
Sujet(s)
Facteur neurotrophique dérivé du cerveau , Cacaoyer , Hippocampe , Mémoire , Souris de lignée C57BL , Neurogenèse , Animaux , Facteur neurotrophique dérivé du cerveau/métabolisme , Facteur neurotrophique dérivé du cerveau/génétique , Neurogenèse/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Souris , Mâle , Femelle , Mémoire/effets des médicaments et des substances chimiques , Cacaoyer/composition chimique , Plasticité neuronale/effets des médicaments et des substances chimiques , Régime alimentaireRÉSUMÉ
Hexaconazole is a widely used and frequently detected fungicide which is also reported to be persistent in environment. The toxicity of Hex to non-organisms such as reproductive toxicity, endocrine disrupting toxicity, and carcinogenic toxicity had been reported. However, study on the Hex-induced neurotoxicity is rare and the mechanism is still unclear. Therefore, in this study, environmental related concentrations of Hex were chosen to investigate the effects of Hex on nervous system from the aspect of biological rhythm under 90 d sub-chronic exposure. The results showed that Hex significantly affected the cognitive function of rats resulting in the deterioration of learning and memory ability and induced oxidative stress in rat brain. Moreover, the notable changes of neurotransmitters in rat brain suggested the disorder of nerve signaling conduction induced by Hex. The influence of Hex on biological rhythm was further detected which showed that levels of rhythm regulatory genes and proteins significantly disturbed at four monitored time periods. Based on these results, it was supposed that the underlying mechanism of Hex-induced cognitive dysfunction might through oxidative stress pathway. Our findings could systematically and comprehensively clarify the effects of Hex on nervous system and were helpful for prevention neurological diseases induced by triazole pesticides.